Skip to main content
. 2022 Mar 24;111(5):1107–1121. doi: 10.1002/JLB.5COVA1121-626R

TABLE 1.

Characteristics of COVID‐19 patients and control subjects

Characteristics 1 Control (n = 10) Asymptomatic/mild (n = 10) Severe/critical (n = 24)
Age, years 53 (32–60) 43 (24–52) 58 (48–66)
Sex, male 4 (40%) 4 (40%) 12 (50%)
Respiratory support
Oxygen supplementation 0 (0%) 0 (0%) 5 (20.8%)
Mechanical ventilation 0 (0%) 0 (0%) 19 (79.2%)
SAPS 3 60 (55–71)
PaO2/FiO2 ratio 154 (99–373)
Vasopressor 10 (41.6%)
Time from symptom onset to blood sample, days 6 (−1 to 8) 2 14 (8–17)
28‐day mortality 13 (54.2%)
Comorbidities
Obesity 1 (10%) 1 (10%) 5 (20.8%)
Hypertension 1 (10%) 2 (20%) 6 (25%)
Diabetes 0 (0%) 0 (0%) 9 (37.5%)
Cancer 0 (0%) 0 (0%) 3 (12.5%)
Heart disease 3 0 (0%) 0 (0%) 2 (8.3%)
Presenting symptoms
Cough 0 (0%) 3 (30%) 17 (70.8%)
Fever 0 (0%) 5 (50%) 18 (75%)
Dyspnea 0 (0%) 0 (0%) 20 (83.3%)
Headache 0 (0%) 4 (40%) 3 (12.5%)
Anosmia 0 (0%) 4 (40%) 8 (33.3%)
Laboratory findings on admission
Leukocytes, ×1000/μl 138 (102–180)
Lymphocyte, cells/μl 1,167 (645–1590)
Monocytes, cells/μl 679 (509–847)
Platelet count, ×1000/μl 169 (137–218)
C reactive protein, mg/l 4 0.1 (0.1–0.18) 0.2 (0.1–0.13) 178 (74–308)*
Fibrinogen, mg/dl 4 281 (232–302) 248 (182–341) 528 (366–714)*
D‐dimer, IU/ml 4 292 (225–476) 191 (187–313) 4836 (2364–10,816)*
1

Numerical variables are represented as the median and the interquartile range, and qualitative variables are represented as the number and the percentage.

2

Day of sample collection after the onset of symptoms was not computed for asymptomatic subjects.

3

Coronary artery disease or congestive heart failure.

4

Reference values of C reactive protein (0.00–1.00), fibrinogen (238–498 mg/dl) and d‐dimer (0–500 ng/ml).

*p < 0.05 compared with control. The qualitative variables were compared using the 2‐tailed Fisher exact test, and the numerical variables using the t‐test for parametric and the Mann–Whitney U test for nonparametric distributions.